Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Long-Term Debt : $32.28 Mil (As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Long-Term Debt?

Parnell Pharmaceuticals Holdings's Long-Term Debt for the quarter that ended in Dec. 2018 was $32.28 Mil.

Parnell Pharmaceuticals Holdings's quarterly Long-Term Debt increased from Dec. 2016 ($21.92 Mil) to Dec. 2017 ($24.60 Mil) and increased from Dec. 2017 ($24.60 Mil) to Dec. 2018 ($32.28 Mil).

Parnell Pharmaceuticals Holdings's annual Long-Term Debt increased from Dec. 2016 ($21.92 Mil) to Dec. 2017 ($24.60 Mil) and increased from Dec. 2017 ($24.60 Mil) to Dec. 2018 ($32.28 Mil).

Parnell Pharmaceuticals Holdings Long-Term Debt Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Long-Term Debt Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Long-Term Debt

Get a 7-Day Free Trial

0.14

10.40

21.92

24.60

32.28

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Long-Term Debt	Get a 7-Day Free Trial			0.14	10.40	21.92	24.60	32.28

Parnell Pharmaceuticals Holdings (OTCPK:PARNF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Parnell Pharmaceuticals Holdings Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.